Article

barrons.com on 2019-08-09 15:10

Nektar Therapeutics Stock Plunges Because There’s No Shortage of Bad News

Shares of biotech firm Nektar Therapeutics collapsed after the company revealed in an earnings call that there had been manufacturing issues in two ...

Related news